JP2023537921A5 - - Google Patents

Info

Publication number
JP2023537921A5
JP2023537921A5 JP2023508551A JP2023508551A JP2023537921A5 JP 2023537921 A5 JP2023537921 A5 JP 2023537921A5 JP 2023508551 A JP2023508551 A JP 2023508551A JP 2023508551 A JP2023508551 A JP 2023508551A JP 2023537921 A5 JP2023537921 A5 JP 2023537921A5
Authority
JP
Japan
Prior art keywords
compound
compound according
pharmaceutically acceptable
pharmaceutical composition
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023508551A
Other languages
English (en)
Japanese (ja)
Other versions
JP7656359B2 (ja
JP2023537921A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/045205 external-priority patent/WO2022035752A1/en
Publication of JP2023537921A publication Critical patent/JP2023537921A/ja
Publication of JP2023537921A5 publication Critical patent/JP2023537921A5/ja
Application granted granted Critical
Publication of JP7656359B2 publication Critical patent/JP7656359B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023508551A 2020-08-10 2021-08-09 アムホテリシンbのハイブリッドアミド誘導体 Active JP7656359B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063063655P 2020-08-10 2020-08-10
US63/063,655 2020-08-10
US202163175771P 2021-04-16 2021-04-16
US63/175,771 2021-04-16
PCT/US2021/045205 WO2022035752A1 (en) 2020-08-10 2021-08-09 Hybrid amide derivatives of amphotericin b

Publications (3)

Publication Number Publication Date
JP2023537921A JP2023537921A (ja) 2023-09-06
JP2023537921A5 true JP2023537921A5 (https=) 2024-08-16
JP7656359B2 JP7656359B2 (ja) 2025-04-03

Family

ID=80247344

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023508551A Active JP7656359B2 (ja) 2020-08-10 2021-08-09 アムホテリシンbのハイブリッドアミド誘導体

Country Status (12)

Country Link
US (1) US20230357303A1 (https=)
EP (2) EP4192248B1 (https=)
JP (1) JP7656359B2 (https=)
KR (1) KR20230061405A (https=)
CN (1) CN116323632B (https=)
AU (1) AU2021325676A1 (https=)
CA (1) CA3190997A1 (https=)
ES (1) ES3061451T3 (https=)
IL (1) IL300441A (https=)
MX (1) MX2023001649A (https=)
PT (1) PT4192248T (https=)
WO (1) WO2022035752A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL122086B1 (en) * 1979-04-09 1982-06-30 Politechnika Gdanska Process for preparing amides of antibiotics from the group of polyene macrolides and their derivativesvykh makrolidov i ikh proizvodnykh
JP3507486B2 (ja) 1991-03-15 2004-03-15 アムジエン・インコーポレーテツド 顆粒球コロニー刺激因子の肺内投与
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US6664241B2 (en) * 2000-05-31 2003-12-16 Micrologix Biotech Inc. Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
ES2749927T3 (es) * 2014-05-16 2020-03-24 Univ Illinois Derivado de anfotericina b con toxicidad reducida
MA39568A1 (fr) * 2014-06-12 2017-09-29 Shionogi & Co Dérivé de macrolide de polyène
JP7240811B2 (ja) * 2015-04-15 2023-03-16 スファンガ セラピューティクス インコーポレイテッド アムホテリシンbの誘導体
CA3111565A1 (en) * 2018-09-07 2020-03-12 The Board Of Trustees Of The University Of Illinois Hybrid amphotericin b derivatives with reduced toxicity
EP4009985A4 (en) * 2019-08-08 2023-09-06 The Board Of Trustees Of The University Of Illinois HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B

Similar Documents

Publication Publication Date Title
JP2023002662A5 (https=)
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
JP2021527092A5 (https=)
CN114641293A (zh) 一种fgfr抑制剂的用途
JP2009102342A5 (https=)
JP2023535744A5 (https=)
JP2014515373A5 (https=)
RU2010140682A (ru) Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство
IL314873A (en) Compositions and methods for treating disorders ameliorated by muscarnic receptor activation
HUE029677T2 (hu) Készítmények centrálisan mediált émelygés és hányás kezelésére
JP2023541432A5 (https=)
JP2007520452A5 (https=)
JP2018513188A5 (https=)
JP2023500032A5 (https=)
JP2022531251A5 (https=)
EP4520394A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
JP2016505050A5 (https=)
JP2023548429A5 (https=)
JP2022035920A5 (https=)
JP2021536506A5 (https=)
JP2023531930A5 (https=)
JP2023537921A5 (https=)
JP2021512086A5 (https=)
CN115607545B (zh) 依达拉奉在自闭症谱系障碍治疗中的应用
CN113557016A (zh) 衣壳组装调节剂固体配制品